Back to Search
Start Over
Does Combination Therapy With SGLT2 Inhibitors and Renin–Angiotensin System Blockers Lead to Greater Reduction in Cardiorenal Events Among Patients With Type 2 Diabetes?
- Source :
- Frontiers in Cardiovascular Medicine, Frontiers in Cardiovascular Medicine, Vol 8 (2021)
- Publication Year :
- 2021
- Publisher :
- Frontiers Media S.A., 2021.
- Subjects :
- medicine.medical_specialty
Opinion
Combination therapy
business.industry
type 2 diabetes mellitus
medicine.medical_treatment
cardiorenal events
Type 2 Diabetes Mellitus
Heart failure
Type 2 diabetes
Cardiovascular Medicine
medicine.disease
RC666-701
Internal medicine
RAS blockers
Renin–angiotensin system
medicine
Cardiology
Diseases of the circulatory (Cardiovascular) system
Cardiology and Cardiovascular Medicine
Lead (electronics)
business
Reduction (orthopedic surgery)
SGLT2 inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 2297055X
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Frontiers in Cardiovascular Medicine
- Accession number :
- edsair.doi.dedup.....bfcb0caaae64eef9b69738cb2b54d392